Neurowave, Alaven Sign Agreement for Device to Treat Pregnancy-Related Nausea

Neurowave Medical Technologies and Alaven Pharmaceutical have entered into an exclusive licensing agreement under which Alaven will commercialize NMT’s patented prescription neuromodulation pulse generator device for the treatment of pregnancy induced nausea and vomiting in the United States.
centredaily